These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

314 related items for PubMed ID: 16680149

  • 21. Cardiac glycosides initiate Apo2L/TRAIL-induced apoptosis in non-small cell lung cancer cells by up-regulation of death receptors 4 and 5.
    Frese S, Frese-Schaper M, Andres AC, Miescher D, Zumkehr B, Schmid RA.
    Cancer Res; 2006 Jun 01; 66(11):5867-74. PubMed ID: 16740726
    [Abstract] [Full Text] [Related]

  • 22. Aspirin sensitizes cancer cells to TRAIL-induced apoptosis by reducing survivin levels.
    Lu M, Strohecker A, Chen F, Kwan T, Bosman J, Jordan VC, Cryns VL.
    Clin Cancer Res; 2008 May 15; 14(10):3168-76. PubMed ID: 18483385
    [Abstract] [Full Text] [Related]

  • 23. Antibodies targeted to TRAIL receptor-2 and ErbB-2 synergize in vivo and induce an antitumor immune response.
    Stagg J, Sharkey J, Pommey S, Young R, Takeda K, Yagita H, Johnstone RW, Smyth MJ.
    Proc Natl Acad Sci U S A; 2008 Oct 21; 105(42):16254-9. PubMed ID: 18838682
    [Abstract] [Full Text] [Related]

  • 24. A novel dendritic cell subset involved in tumor immunosurveillance.
    Taieb J, Chaput N, Ménard C, Apetoh L, Ullrich E, Bonmort M, Péquignot M, Casares N, Terme M, Flament C, Opolon P, Lecluse Y, Métivier D, Tomasello E, Vivier E, Ghiringhelli F, Martin F, Klatzmann D, Poynard T, Tursz T, Raposo G, Yagita H, Ryffel B, Kroemer G, Zitvogel L.
    Nat Med; 2006 Feb 21; 12(2):214-9. PubMed ID: 16444265
    [Abstract] [Full Text] [Related]

  • 25. Anti-tumor activity of TRA-8 anti-death receptor 5 (DR5) monoclonal antibody in combination with chemotherapy and radiation therapy in a cervical cancer model.
    Straughn JM, Oliver PG, Zhou T, Wang W, Alvarez RD, Grizzle WE, Buchsbaum DJ.
    Gynecol Oncol; 2006 Apr 21; 101(1):46-54. PubMed ID: 16271751
    [Abstract] [Full Text] [Related]

  • 26. Gene transfer of CD40-ligand to dendritic cells stimulates interferon-gamma production to induce growth arrest and apoptosis of tumor cells.
    Tomihara K, Kato K, Masuta Y, Nakamura K, Uchida H, Sasaki K, Tanaka T, Huang J, Hiratsuka H, Hamada H.
    Gene Ther; 2008 Feb 21; 15(3):203-13. PubMed ID: 17989706
    [Abstract] [Full Text] [Related]

  • 27. Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion.
    Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, Roche PC, Lu J, Zhu G, Tamada K, Lennon VA, Celis E, Chen L.
    Nat Med; 2002 Aug 21; 8(8):793-800. PubMed ID: 12091876
    [Abstract] [Full Text] [Related]

  • 28. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B, Wu X, Mao Y, Bao W, Gao L, Zhou P, Xie R, Zhou L, Zhu J.
    Neurosurgery; 2009 Sep 21; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [Abstract] [Full Text] [Related]

  • 29. Target cell-restricted apoptosis induction of acute leukemic T cells by a recombinant tumor necrosis factor-related apoptosis-inducing ligand fusion protein with specificity for human CD7.
    Bremer E, Samplonius DF, Peipp M, van Genne L, Kroesen BJ, Fey GH, Gramatzki M, de Leij LF, Helfrich W.
    Cancer Res; 2005 Apr 15; 65(8):3380-8. PubMed ID: 15833872
    [Abstract] [Full Text] [Related]

  • 30. Oral adeno-associated virus-sTRAIL gene therapy suppresses human hepatocellular carcinoma growth in mice.
    Ma H, Liu Y, Liu S, Xu R, Zheng D.
    Hepatology; 2005 Dec 15; 42(6):1355-63. PubMed ID: 16317690
    [Abstract] [Full Text] [Related]

  • 31. Interferon-activated neutrophils store a TNF-related apoptosis-inducing ligand (TRAIL/Apo-2 ligand) intracellular pool that is readily mobilizable following exposure to proinflammatory mediators.
    Cassatella MA, Huber V, Calzetti F, Margotto D, Tamassia N, Peri G, Mantovani A, Rivoltini L, Tecchio C.
    J Leukoc Biol; 2006 Jan 15; 79(1):123-32. PubMed ID: 16244105
    [Abstract] [Full Text] [Related]

  • 32. Low-dose 12-O-tetradecanoylphorbol-13-acetate enhances tumor necrosis factor related apoptosis-inducing ligand induced apoptosis in prostate cancer cells.
    Zhang X, Li W, Olumi AF.
    Clin Cancer Res; 2007 Dec 01; 13(23):7181-90. PubMed ID: 18056199
    [Abstract] [Full Text] [Related]

  • 33. Targeting pro-apoptotic trail receptors sensitizes HeLa cervical cancer cells to irradiation-induced apoptosis.
    Maduro JH, de Vries EG, Meersma GJ, Hougardy BM, van der Zee AG, de Jong S.
    Int J Radiat Oncol Biol Phys; 2008 Oct 01; 72(2):543-52. PubMed ID: 18793956
    [Abstract] [Full Text] [Related]

  • 34. Bortezomib sensitizes non-Hodgkin's lymphoma cells to apoptosis induced by antibodies to tumor necrosis factor related apoptosis-inducing ligand (TRAIL) receptors TRAIL-R1 and TRAIL-R2.
    Smith MR, Jin F, Joshi I.
    Clin Cancer Res; 2007 Sep 15; 13(18 Pt 2):5528s-5534s. PubMed ID: 17875785
    [Abstract] [Full Text] [Related]

  • 35. Established B16 tumors are rejected following treatment with GM-CSF-secreting tumor cell immunotherapy in combination with anti-4-1BB mAb.
    Li B, Lin J, Vanroey M, Jure-Kunkel M, Jooss K.
    Clin Immunol; 2007 Oct 15; 125(1):76-87. PubMed ID: 17706463
    [Abstract] [Full Text] [Related]

  • 36. TRAIL resistance of breast cancer cells is associated with constitutive endocytosis of death receptors 4 and 5.
    Zhang Y, Zhang B.
    Mol Cancer Res; 2008 Dec 15; 6(12):1861-71. PubMed ID: 19074831
    [Abstract] [Full Text] [Related]

  • 37. [Role of caspase-8 and DR5 in TRAIL-induced apoptosis of neuroblastoma cells].
    Tong HX, Zhang JH, Ma L, Lu CW, Zhang JH.
    Zhongguo Dang Dai Er Ke Za Zhi; 2006 Aug 15; 8(4):327-30. PubMed ID: 16923369
    [Abstract] [Full Text] [Related]

  • 38. Prognostic significance of tumor necrosis factor-related apoptosis-inducing ligand and its receptors in adjuvantly treated stage III colon cancer patients.
    van Geelen CM, Westra JL, de Vries EG, Boersma-van Ek W, Zwart N, Hollema H, Boezen HM, Mulder NH, Plukker JT, de Jong S, Kleibeuker JH, Koornstra JJ.
    J Clin Oncol; 2006 Nov 01; 24(31):4998-5004. PubMed ID: 17075118
    [Abstract] [Full Text] [Related]

  • 39. Local activation of CD8 T cells and systemic tumor eradication without toxicity via slow release and local delivery of agonistic CD40 antibody.
    Fransen MF, Sluijter M, Morreau H, Arens R, Melief CJ.
    Clin Cancer Res; 2011 Apr 15; 17(8):2270-80. PubMed ID: 21389097
    [Abstract] [Full Text] [Related]

  • 40. Combined natural killer T-cell based immunotherapy eradicates established tumors in mice.
    Teng MW, Westwood JA, Darcy PK, Sharkey J, Tsuji M, Franck RW, Porcelli SA, Besra GS, Takeda K, Yagita H, Kershaw MH, Smyth MJ.
    Cancer Res; 2007 Aug 01; 67(15):7495-504. PubMed ID: 17671220
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.